Fang Ni
Finanzdirektor/CFO bei BLACK DIAMOND THERAPEUTICS, INC.
Vermögen: 655 761 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Fang Ni
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fang Ni
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AXCA HEALPAR | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Private Equity Investor Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| CRISPR THERAPEUTICS AG | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
| Yale University | College/University | Corporate Officer/Principal Doctorate Degree | |
Calico LLC
 Calico LLC BiotechnologyHealth Technology Part of Alphabet, Inc., Calico LLC conducts research into the biology of aging. The company is based in South San Francisco, CA. Arthur D. Levinson has been the CEO of the company since 2013. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Princeton University | College/University | Doctorate Degree Doctorate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Okairos SRL
 Okairos SRL Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Okairos SRL is an Italian company that manufactures drugs. The company is based in Rome, Italy. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AMYRIS, INC. | Chemicals: Specialty | Director/Board Member Chairman | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| STOKE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| NUVATION BIO INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Versant Ventures (Switzerland) GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
| METASTAT, INC. | Electrical Products | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Launchpad Therapeutics, Inc.
 Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Launchpad Therapeutics, Inc. develops novel therapeutics. | Miscellaneous Commercial Services | Director/Board Member President | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Chairman Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Brandeis University | College/University | Doctorate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
| REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Pharmaceuticals: Generic | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 37 |
| Schweiz | 6 |
| Vereinigtes Königreich | 5 |
| Italien | 2 |
| Finnland | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 4 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 286 |
| Corporate Officer/Principal | 144 |
| Independent Dir/Board Member | 94 |
| Chairman | 66 |
| Chief Tech/Sci/R&D Officer | 37 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Bradley Bolzon | 41 |
| Kapil Dhingra | 39 |
| Ali Behbahani | 34 |
| Luba Greenwood | 32 |
| William Burns | 27 |
| Patrick Yang | 27 |
| Claudia Dyckerhoff | 26 |
| Wendy Dixon | 25 |
| Zafrira Avnur | 20 |
| Arthur Levinson | 19 |
| Garry Menzel | 19 |
| Alexander Mayweg | 18 |
| Hyam Levitsky | 18 |
| Rachel Humphrey | 17 |
